Intradermal vaccination using the novel microneedle device MicronJet600: Past, present, and future

References

• Gross CP, Sepkowitz KA. The myth of the medical breakthrough: Smallpox, vaccination, and Jenner reconsidered. IJID 1998; 3:54-60; PMID:9831677. http://www.ijidonline.com/article/S1201-9712(98)90096-0/pdf
   PubMedGoogle Scholar
• Millar JD, Foege W.H. Status of eradication of smallpox (and control of measles) in West and Central Africa. J Infect Dis 1969; 120:725-32; PMID:5374972; http://dx.doi.org/10.1093/infdis/120.6.725
   PubMedGoogle Scholar
• Jenner E. An Inquiry into the Causes and Effects of the Variolae Vaccinae: A Disease Discovered in Some of the Western Counties of England, Particularly Gloucestershire, and Known by the Name of the Cow Pox. London: Sampson Low; 1798, 1-2
   Google Scholar
• Jenner E. Two cases of small-pox infection communicated to the foetus in utero under peculiar circumstances, with additional remarks. Med Chir Trans 1809; 1:271-7; PMID:20895118. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2128795/pdf/medcht00073-0301.pdf
   PubMedGoogle Scholar
• Payette PJ, Davis HL. History of vaccines and positioning of current trends. Curr Drug Targets Infect Disord 2001; 1:241; PMID:12455398; http://dx.doi.org/10.2174/1568005014606017
   PubMedGoogle Scholar
• Jenner E, Razzell PE. The history of a medical myth. Med Hist 1965; 9:216-29. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1033502/pdf/medhist00154-0020.pdf
   PubMedGoogle Scholar
• Calmette A. Preventive vaccination against tuberculosis with BCG. Proc R Soc Med 1931; 24:1481. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2182232/pdf/procrsmed00808-0023.pdf
   PubMedGoogle Scholar
• Mantoux C. L’intradermo-reaction a la tuberculine et son interpretation clinique. Presse Med 1910; 18:10-3
   Google Scholar
• Flynn PM, Shenep JL, Mao L, Crawford R, Williams BF, Williams BG. Influence of needle gauge in Mantoux skin testing. Chest 1994; 106:1463-65; PMID:7956403; http://dx.doi.org/10.1378/chest.106.5.1463
   PubMed Web of Science ®Google Scholar
• Tarnow K, King N. Intradermal injections: traditional bevel up versus bevel down. ANR 2004; 17:275-82; PMID:15573336; http://dx.doi.org/10.1016/j.apnr.2004.09.009
   PubMedGoogle Scholar
• Lambert PH, Laurent PE. Intradermal vaccine delivery: Will new delivery systems transform vaccine administration? Vaccine 2008; 26:3197-208; PMID:18486285; http://dx.doi.org/10.1016/j.vaccine.2008.03.095
   PubMed Web of Science ®Google Scholar
• Dacso CC. Skin Testing for Tuberculosis. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Boston: Butterworths; 1990. Chapter 47. Available from: http://www.ncbi.nlm.nih.gov/books/NBK369/
   Google Scholar
• Salisbury DM, Begg NT(Eds.). 1996. Immunisation against infectious disease: the green book. Department of Health, London.
   Google Scholar
• Frösner G, Steffen R, Herzog C. Virosomal hepatitis A vaccine: Comparing intradermal and subcutaneous with intramuscular administration. J Travel Med 2009; 16:413-9; PMID:19930383; http://dx.doi.org/10.1111/j.1708-8305.2009.00351.x
   PubMed Web of Science ®Google Scholar
• Pancharoen C, Mekmullica J, Thisyakorn U, Kasempimolporn S, Wilde H, Herzog C. Reduced-dose intradermal vaccination against hepatitis A with an aluminum-free vaccine is immunogenic and can lower costs. CID 2005; 41:1537-40; PMID:16231271; http://dx.doi.org/10.1086/497266
   PubMed Web of Science ®Google Scholar
• Chen W, Gluud C. Vaccines for preventing hepatitis B in health-care workers. Cochrane Database of Systematic Reviews 2005; Issue 4. Art. No.: CD000100. DOI: 10.1002/14651858.CD000100.pub3
   Web of Science ®Google Scholar
• Sangare L, Manhart L, Zehrung D, Wang CC. Intradermal hepatitis B vaccination: A systematic review and meta-analysis. Vaccine 2009; 27:1777-86; http://dx.doi.org/10.1016/j.vaccine.2009.01.043
   PubMed Web of Science ®Google Scholar
• Braddick MR. Intradermal hepatitis B vaccine. Lancet 1989; 1:957-8; http://dx.doi.org/10.1016/S0140-6736(89)92533-6
   PubMed Web of Science ®Google Scholar
• Redfield RR, Innis BL, Scott RM, Cannon HG, Bancroft WH. Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine—A cost reduction strategy. JAMA 1985; 254:3203-6; PMID:2933535; http://dx.doi.org/10.1001/jama.1985.03360220069031
   PubMed Web of Science ®Google Scholar
• Wistrom J. Intramuscular vs. intradermal hepatitis B vaccination: A 6-year follow-up. JAMA 1995; 273:1835-6; PMID:7776497; http://dx.doi.org/10.1001/jama.1995.03520470043027
   PubMedGoogle Scholar
• Kyi KP, Oo KM, Htun MM, Tun WM, Aye KK, Oo SS, Lwin KO, Nyunt S. Clinical trial of the intradermal administration of hepatitis B vaccine produced at the Department of Medical Research, Myanmar. Vaccine 2002; 20:1649-52; PMID:11858874; http://dx.doi.org/10.1016/S0264-410X(01)00468-6
   PubMedGoogle Scholar
• Fishbein DB, Pacer RE, Holmes DF, Ley AB, Yager P, Tong TC. Rabies pre exposure prophylaxis with human diploid cell rabies vaccine: A dose–response study. J Infect Dis 1987; 156:50-5; http://dx.doi.org/10.1093/infdis/156.1.50
   PubMed Web of Science ®Google Scholar
• Warrell MJ, Warrell DA, Nicholson KG, Suntharasamai P, Chanthavanich P, Viravan C, Udomsakdi D. Economical multiple-site intradermal immunisation with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis. Lancet 1985; 325:1059-62; PMID:2860284; http://dx.doi.org/10.1016/S0140-6736(85)92367-0
   PubMedGoogle Scholar
• Quimbao BP, Dimaano EM, Ambas C, Davis R, Banzhoff A, Malerczyk C. Reducing the cost of post-exposure rabies prophylaxis: Efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals. Vaccine 2005; 23:1709-14; PMID:15705476; http://dx.doi.org/10.1016/j.vaccine.2004.09.027
   PubMedGoogle Scholar
• Khawplod P, Wilde H, Sirikwin S, Benjawonqkulchai M, Limusanno S, Jaijaroensab W, Chiraguna N, Supich C, Wangroongsarb Y, Sitprija V. Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection. Vaccine 2006; 24:3084-6; PMID:16494972; http://dx.doi.org/10.1016/j.vaccine.2006.01.051
   PubMed Web of Science ®Google Scholar
• World Health Organization. Rabies vaccines. WHO position paper. Wkly Epi demiol Rec 2010; 85:309-20. http://www.who.int/wer/2010/wer8532.pdf?ua=1
   Google Scholar
• Hung IF, Levin Y, To KK. Quantitative and qualitative analysis of antibody response after dose sparing intradermal 2009 H1N1 vaccination. Vaccine 2012; 30:707-2708; PMID:22210225; http://dx.doi.org/10.1016/j.vaccine.2011.12.069
   PubMedGoogle Scholar
• Whittle HC, Rowland MG, Mann GF, Lamb WH, Lewis RA. Immunisation of 4–6 month old Gambian infants with Edmonston-Zagreb measles vaccine. Lancet 1984; 2:834-7; PMID:6148572; http://dx.doi.org/10.1016/S0140-6736(84)90873-0
   PubMedGoogle Scholar
• Edens C, Collins ML, Ayers J, Rota PA, Prausnit MR. Measles vaccination using a microneedle patch. Vaccine 2013; 31:3403-9; PMID:23044406; http://dx.doi.org/10.1016/j.vaccine.2012.09.062
   PubMed Web of Science ®Google Scholar
• Burland WL. Measles vaccination by the intradermal route. Postgrad Med J 1969; 45:323-6; http://dx.doi.org/10.1136/pgmj.45.523.323
   PubMed Web of Science ®Google Scholar
• Icardi G, Orsi A, Ceravolo A, Ansaldi F. Current evidence on intradermal influenza vaccines administered by SoluviaTM licensed micro injection system. Hum Vaccin Immunother 2012; 8:67-75; PMID:22293531; http://dx.doi.org/10.4161/hv.8.1.18419
   PubMed Web of Science ®Google Scholar
• Arnou R, Eavis P, Pardo JR, Ambrozaitis A, Kazek MP, Weber F. Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18–60 years: Randomized, controlled, phase III trial. Hum Vaccine 2010; 6:346-54; PMID:20372053; http://dx.doi.org/10.4161/hv.6.4.10961
   PubMed Web of Science ®Google Scholar
• Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y. Safety and efficacy of a novel microneedle device for dose sparing intra-dermal influenza vaccination in healthy adults. Vaccine 2009; 27:454-9; PMID:19022318; http://dx.doi.org/10.1016/j.vaccine.2008.10.077
   PubMed Web of Science ®Google Scholar
• Belshe RB, Newman FK, Wilkins K, Graham IL, Babusis E, Ewell M, Frey SE. Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine 2007; 25:6755-63
   PubMed Web of Science ®Google Scholar
• Tsang P, Gorse GJ, Strout CB, Sperling M, Greenberg DP, Ozol-Godfrey A, Diaz-Granados C, Landolfi V. Immunogenicity and safety of Fluzone® intradermal and high-dose influenza vaccines in older adults ≥65 years of age: A randomized, controlled, phase II trial. Vaccine 2014; 32:2507-17; PMID:24120672; http://dx.doi.org/10.1016/j.vaccine.2013.09.074
   PubMed Web of Science ®Google Scholar
• Levin Y, Kochba E, Kenney R. Clinical evaluation of a novel microneedle device for intradermal delivery of an influenza vaccine: Are all delivery methods the same? Vaccine 2014; 32:4249-52; PMID:24930715; http://dx.doi.org/10.1016/j.vaccine.2014.03.024
   PubMed Web of Science ®Google Scholar
• Roukens AH, Vossen AC, Bredenbeek PJ, Van Dissel JT, Visser LG. Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial. PLoS One 2008; 3:e1993; PMID:18431480; http://dx.doi.org/10.1371/journal.pone.0001993
   PubMed Web of Science ®Google Scholar
• Roukens AH, Vossen AC, Van Dissel JT, Visser LG. Reduced intradermal test dose 240 of yellow fever vaccine induces protective immunity in individuals with egg 241 allergy. Vaccine 2009; 27:2408-9; PMID:19368780; http://dx.doi.org/10.1016/j.vaccine.2009.02.049
   PubMed Web of Science ®Google Scholar
• Hickling J, Jones R. Yellow fever vaccination: The potential of dose-sparing to increase vaccine supply and availability. PATH report. April 18, 2013. http://www.path.org/publications/files/TS_vtg_yf_rpt.pdf. Retrieved August 1st, 2014
   Google Scholar
• Mohammed AJ, AlAwaidy S, Bawikar S, Kurup PJ, Elamir E, Shaban M, Sharif SM, Van Der Avoort H, Pallansch MA, Malankar P, et al. Fractional doses of inactivated poliovirus vaccine in Oman. N Engl J Med 2010; 362:2351-9; PMID:20573923; http://dx.doi.org/10.1056/NEJMoa0909383
   PubMed Web of Science ®Google Scholar
• Resik S, Tejeda A, Lago PM, Diaz M, Carmenates A, Sarmiento L, Alemañi N, Galindo B, Burton A, Friede M, et al. Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba. J Infect Dis 2010; 201:1344-52; PMID:20350164; http://dx.doi.org/10.1086/651611
   PubMed Web of Science ®Google Scholar
• Nirmal S, Cherian T, Samuel BU, Rajasinght J, Raghupathy P, Jacob JT. Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine. Vaccine 1998; 16:928-31; http://dx.doi.org/10.1016/S0264-410X(97)00293-4
   PubMed Web of Science ®Google Scholar
• Estívariz CF, Jafari H, Sutter RW, John TJ, Jain V, Agarwal A, Verma H, Pallansch MA, Singh AP, Guirguis S, et al. Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6–9 months in Moradabad, India: A community-based, randomised controlled trial. Lancet Infect Dis 2012; 12:128-35; PMID:22071249; http://dx.doi.org/10.1016/S1473-3099(11)70190-6
   PubMed Web of Science ®Google Scholar
• Zoulek G, Roggendorf M, Deinhardt F, Kunz C. Different immune responses after intradermal and intramuscular administration of vaccine against tick borne encephalitis virus. J Med Virol 1986; 19:55-61; PMID:3701303; http://dx.doi.org/10.1002/jmv.1890190109
   PubMed Web of Science ®Google Scholar
• Baxby D. Smallpox vaccination techniques; from knives and forks to needles and pins. Vaccine 2002; 20:2140-9; PMID:11972983; http://dx.doi.org/10.1016/S0264-410X(02)00028-2
   PubMed Web of Science ®Google Scholar
• Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 2004; 351:2295-301; PMID:15525714; http://dx.doi.org/10.1056/NEJMoa043540
   PubMed Web of Science ®Google Scholar
• Brown LE. The role of adjuvants in vaccines for seasonal and pandemic influenza. Vaccine 2010; 28:8043-5; http://dx.doi.org/10.1016/j.vaccine.2010.09.024
   PubMed Web of Science ®Google Scholar
• Nordin J, Mullooly J, Poblete S, Strikas R, Petrucci R, Wei F, Rush B, Safirstein B, Wheeler D, Nichol KL. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: Data from 3 health plans. J Infect Dis 2001; 184:665-70; http://dx.doi.org/10.1086/323085
   PubMed Web of Science ®Google Scholar
• Gill HS, Kang SM, Quan FS, Compans RW. Cutaneous immunization: An evolving paradigm in influenza vaccines. Expert Opin Drug Deliv 2014; 11:615-27; PMID:24521050; http://dx.doi.org/10.1517/17425247.2014.885947
   PubMed Web of Science ®Google Scholar
• Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331:778-84; PMID:8065407; http://dx.doi.org/10.1056/NEJM199409223311206
   PubMed Web of Science ®Google Scholar
• Resik S, Tejeda A, Sutter RW, Diaz M, Sarmiento L, Alemañi N, Aylward RB. Priming after a fractional dose of inactivated poliovirus vaccine. N Engl J Med 2013; 368:416-24; PMID:23363495; http://dx.doi.org/10.1056/NEJMoa1202541
   PubMed Web of Science ®Google Scholar
• Hickling J, Jones R, Nundy N. Improving the affordability of inactivated poliovirus vaccines (IPV) for use in low-and middle-income countries: PATH (Program for Appropriate Technology in Health), 2010. http://www.path.org/publications/files/TS_IPV_econ_analysis.pdf
   Google Scholar
• Meeting of the Strategic Advisory Group of Experts on immunization, April 2012–—Conclusions and recommendations. 25 May 2012, vol. 87, 21 (pp 201-16).http://www.who.int/wer. Retrieved on August 1, 2014
   Google Scholar
• Polio Eradication and Endgame Strategic Plan 2013–2018. http://www.polioeradication.org/resourcelibrary/strategyandwork.aspx#sthash.IF1yZB1Z. Retrieved on August 1, 2014
   Google Scholar
• Zehrung D Kristensen D. Intradermal Delivery of Vaccines: A Review of the Literature and the Potential for Development for Use in Low- and Middle-Income Countries. August 27, 2009 http://www.path.org/publications/detail.php?i=1746.
   Google Scholar
• Tuft L. The skin as an immunological organ with results of experimental investigations and review of the literature. J Immunol 1931; 21:85-100. http://www.jimmunol.org/content/21/2/85.abstract
   Google Scholar
• Francis T, Magill TP. The antibody response of human subjects vaccinated with the virus of human influenza. J Exp Med 1937; 65:251-9; PMID:19870599; http://dx.doi.org/10.1084/jem.65.2.251
   PubMedGoogle Scholar
• Fluzone Prescribing Information". Sanofi Pasteur. April 2013
   Google Scholar
• World Health Organization: WHO recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies. WHO/EMC/ZOO.96.6. 1997. http://whqlibdoc.who.int/hq/1996/WHO_EMC_ZOO_96.6.pdf
   Google Scholar
• Holland D, Booy R, De Looze F, Eizenberg P, McDonald J, Karrasch J, McKeirnan M, Salem H, Mills G, Reid J, et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: A randomized controlled trial. J Infect Dis 2008; 198:650-8; PMID:18652550; http://dx.doi.org/10.1086/590434
   PubMed Web of Science ®Google Scholar
• Laurent PE, Bonnet S, Alchas P, Regolini P, Mikszta JA, Pettis R, Harvey NG. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 2007; 25:8833-42; PMID:18023942; http://dx.doi.org/10.1016/j.vaccine.2007.10.020
   PubMed Web of Science ®Google Scholar
• Arnou R, Icardi G, De Decker M, Ambrozaitis A, Kazek MP, Weber F, Van Damme P. Intradermal influenza vaccine for older adults: A randomized controlled multicenter phase III study. Vaccine 2009; 27:7304-12; PMID:19849996; http://dx.doi.org/10.1016/j.vaccine.2009.10.033
   PubMed Web of Science ®Google Scholar
• Intanza–Seasonal Influenza Vaccine For Intradermal Use–NHS July 2012 http://hertsvalleysccg.nhs.uk/uploads/file/Pharmacy/Local%20Decisions/Intanza%20intradermal%20influenza%20vaccine%20201207(HMMC).pdf
   Google Scholar
• Puig-Barberà J, Natividad-Sancho A, Calabuig-Pérez J, Lluch-Rodrigo JA, Pastor-Villalba E, Martínez-Úbeda S, Díez-Domingo J. Intradermal and virosomal influenza vaccines for preventing influenza hospitalization in the elderly during the 2011–2012 influenza season: A comparative effectiveness study using the Valencia health care information system. Vaccine 2014; 32:5447-54; http://dx.doi.org/10.1016/j.vaccine.2014.07.095
   PubMed Web of Science ®Google Scholar
• Filippelli M., Lionetti E., Gennaro A., Lanzafame A., Arrigo T., Salpietro C., La Rosa M., Salvatore L. Hepatitis B vaccine by intradermal route in non responder patients: An update. World J Gastroenterol 2014; 20(30):10383-94
   PubMed Web of Science ®Google Scholar
• Launay O, Van der Vliet D, Rosenberg AR, Michel ML, Piroth L, Rey D, de Verdière NC, Slama L, Martin K, Lortholary O, et al. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard Hepatitis B vaccine regimen in adults with HIV-1. JAMA 2011; 305:1432-40; PMID:21486976; http://dx.doi.org/10.1001/jama.2011.351
   PubMed Web of Science ®Google Scholar
• Fabrizi F, Dixit V, Messa P, Martin P. Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: A meta-analysis of randomized trials. J Viral Hepat 2011; 18:730-7; PMID:20819147; http://dx.doi.org/10.1111/j.1365-2893.2010.01354.x
   PubMed Web of Science ®Google Scholar
• Marra F, Young F, Richardson K, Marra CA. A meta-analysis of intradermal versus intramuscular influenza vaccines: immunogenicity and adverse events. Influenza Other Respir Viruses 2013; 7:584-603; PMID:2297417410.1111/irv.12000
   PubMed Web of Science ®Google Scholar
• Kis EE, Winter G, Myschik J. Devices for intradermal vaccination. Vaccine 2012; 30:523-38; http://dx.doi.org/10.1016/j.vaccine.2011.11.020
   PubMed Web of Science ®Google Scholar
• Auewarakul P, Kositanont U, Sornsathapornkul P, Tothong P, Kanyok R, Thongcharoen P. Antibody responses after dose-sparing intradermal influenza vaccination. Vaccine 2007; 25:659-63; PMID:17011678; http://dx.doi.org/10.1016/j.vaccine.2006.08.026
   PubMed Web of Science ®Google Scholar
• Brown H, Kasel JA, Freeman DM, Moise LD, Grose NP, Couch RB. The immunizing effect of influenza A/New Jersey/76 (Hsw1N1) virus vaccine administered intradermally and intramuscularly to adults. J Infect Dis 1977; 136 :S466-S471; PMID:606768; http://dx.doi.org/10.1093/infdis/136.Supplement_3.S466
   PubMed Web of Science ®Google Scholar
• Chiu SS, Peiris JS, Chan KH, Wong WH, Lau YL. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children. Pediatrics 2007; 119:1076-108; PMID:17545373; http://dx.doi.org/10.1542/peds.2006-3176
   PubMed Web of Science ®Google Scholar
• Halperin W, Weiss WI, Altman R, Diamond MA, Black KJ, Iaci AW, Black HC, Goldfield M. A comparison of the intradermal and subcutaneous routes of influenza vaccination with A/New Jersey/76 (swine flu) and A/Victoria/75: Report of a study and review of the literature. Am J Public Health 1979; 69:1247-51; PMID:507256; http://dx.doi.org/10.2105/AJPH.69.12.1247
   PubMed Web of Science ®Google Scholar
• Herbert FA, Larke RP, Markstad EL. Comparison of responses to influenza A/New Jersey/76-A/Victoria/75 virus vaccine administered intradermally or subcutaneously to adults with chronic respiratory disease. J Infect Dis 1979; 140:234-8; PMID:479641; http://dx.doi.org/10.1093/infdis/140.2.234b
   PubMed Web of Science ®Google Scholar
• Samuel BU, Cherian T, Sridharan G, Mukundan P, John TJ. Immune response to intradermally injected inactivated poliovirus vaccine. Lancet 1991; 338:343-4; PMID:1677699; http://dx.doi.org/10.1016/0140-6736(91)90480-D
   PubMed Web of Science ®Google Scholar
• Samuel BU, Cherian T, Rajasingh J, Raghupathy P, John TJ. Immune response of infants to inactivated poliovirus vaccine injected intradermally. Vaccine 1992; 10:135; PMID:1311491; http://dx.doi.org/10.1016/0264-410X(92)90039-M
   PubMed Web of Science ®Google Scholar
• Laurent PE, Bourhy H, Fantino M, Alchas P, Mikszta JA. Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults. Vaccine 2010; 28:5850-6; PMID:20600481; http://dx.doi.org/10.1016/j.vaccine.2010.06.062
   PubMed Web of Science ®Google Scholar
• Mikszta JA, Dekker JP III, Harvey NG, Dean CH, Brittingham JM, Huang J, Sullivan VJ, Dyas B, Roy CJ, Ulrich RG. Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine. Infect Immun 2006; 74:6806-10; PMID:17030580; http://dx.doi.org/10.1128/IAI.01210-06
   PubMed Web of Science ®Google Scholar
• McAllister DV, Wang PM, Davis SP, Park J-H, Canatella PJ, Allen MG, Prausnitz MR. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies. PNAS 2003; 100:13755-60; PMID:14623977; http://dx.doi.org/10.1073/pnas.2331316100
   PubMed Web of Science ®Google Scholar
• Wang PM, Cornwell M, Hill J, Prausnitz MR. Precise microinjection into skin using hollow microneedles. J Invest Dermatol 2006; 126:1080-7; PMID:16484988; http://dx.doi.org/10.1038/sj.jid.5700150
   PubMed Web of Science ®Google Scholar
• Daugimont L, Baron N, Vandermeulen G, Pavselj N, Miklavcic D, Jullien MC, Cabodevila G, Mir LM, Préat V. Hollow microneedle arrays for intradermal drug delivery and DNA electroporation. J Membr Biol 2010; 236:117-25; PMID:20652559; http://dx.doi.org/10.1007/s00232-010-9283-0
   PubMed Web of Science ®Google Scholar
• Prausnitz MR. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 2004; 56:581-7; http://dx.doi.org/10.1016/j.addr.2003.10.023
   PubMed Web of Science ®Google Scholar
• Vrdoljak A. Review of recent literature on microneedle vaccine delivery technologies. Vaccine 2013; 3:47-55; http://dx.doi.org/10.2147/VDT.S34682
   Google Scholar
• Pokorná D, Poláková I, Kindlová M, Dusková M, Ludvíková V, Gabriel P, Kutinová L, Müller M, Šmahel M. Vaccination with human papillomavirus type 16-derived peptides using a tattoo device. Vaccine 2009; 27:3519-29; PMID:19464530; http://dx.doi.org/10.1016/j.vaccine.2009.03.073
   PubMedGoogle Scholar
• Pokorna D, Rubio I, Muller M. DNA-vaccination via tattooing induces stronger humoral and cellular immune responses than intramuscular delivery supported by molecular adjuvants. Genet Vaccines 2008; 6:4; PMID:18257910; http://dx.doi.org/10.1186/1479-0556-6-4
   PubMedGoogle Scholar
• Van den Berg JH, Nuijen B, Beijnen JH, Vincent A, van Tinteren H, Kluge Jr, Woerdeman LA, Hennink WE, Storm G, Schumacher TN et al. Optimization of intradermal vaccination by DNA tattooing in human skin. Hum Gene Ther 2009; 20:181-9; PMID:19301471; http://dx.doi.org/10.1089/hgt.2008.073
   PubMed Web of Science ®Google Scholar
• Ciernik IF, Krayenbühl BH, Carbone DP. Puncture-mediated gene transfer to the skin. Hum Gene Ther 1996; 7:893-9; PMID:8727503; http://dx.doi.org/10.1089/hum.1996.7.8-893
   PubMed Web of Science ®Google Scholar
• Bins AD, Jorritsma A, Wolkers MC, Hung CF, Wu TC, Schumacher TNM, Haanen JB. A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression. Nat Med 2005; 11:899-904; PMID:15965482; http://dx.doi.org/10.1038/nm1264
   PubMed Web of Science ®Google Scholar
• Quaak SG, van den Berg JH, Oosterhuis K, Beijnen JH, Haanen JBAG, Nuijen B. DNA tattoo vaccination: effect on plasmid purity and transfection efficiency of different topoisoforms. J Control Release 2009; 139:153-9; PMID:19580829; http://dx.doi.org/10.1016/j.jconrel.2009.06.033
   PubMedGoogle Scholar
• Ten Dam HG, Fillastre C, Conge G, Orssaud E, Gateff C, Tanaka A, Ramirez OO, Collas R, Wright J, Chambon L et al. The use of jet-injectors in BCG vaccination. Bull WHO 1970; 43:707-20. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427792/pdf/bullwho00209-0064.pdf
   PubMed Web of Science ®Google Scholar
• Stanfield JP, Bracken PM, Waddell KM, Gall D. Diphtheria-Tetanus-Pertussis immunization by intradermal jet injection. Br Med J 1972; 2:197-9; PMID:5022729. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1787936/pdf/brmedj02200-0029.pdf
   PubMed Web of Science ®Google Scholar
• Soonawala D, Verdijk P, Wijmenga-Monsuur AJ, Boog CJ, Koedam P, Visser LG, Rots NY. Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults. Vaccine 2013; 31:3688-94; PMID:23770332; http://dx.doi.org/10.1016/j.vaccine.2013.05.104
   PubMed Web of Science ®Google Scholar
• Dimache G1, Stoean C, Durbacă S, Croitoru M, Ionescu M, Nedelcu IN, Corbu I. Study of specific immune response to unadsorbed concentrated tetanus vaccine administered by intradermal route to non-immunized persons in the last ten years. Arch Roum Pathol Exp Microbiol 1990; 49:51-62; PMID:2101203
   PubMedGoogle Scholar
• Dimache G, Croitoru M, Dimache V, Cuteanu I, Vasilescu T. Lyophilized typhoid vaccine for intradermal use. J Biol Stand 1983; 11:261-9; PMID:6643508; http://dx.doi.org/10.1016/S0092-1157(83)80014-6
   PubMedGoogle Scholar
• Dimache G, Croitoru M, Nicolae IN. Subcutaneous versus intradermal typhoid vaccination by "jet-injector" apparatus. Arch Roum Pathol Exp Microbiol 1982; 41:259-64; PMID:7159215
   PubMedGoogle Scholar
• Dimache G, Dimache V, Ciudin L, Palade R, Croitoru M. Intradermal typhoid vaccination in men by jet-injector. Immunological estimation by laboratory tests. Arch Roum Pathol Exp Microbiol 1976; 36:227-32; PMID:617039
   PubMedGoogle Scholar
• Bernard KW, Roberts MA, Sumner J, Winkler WG, Mallonee J, Baer GM, Chaney R. Human diploid cell rabies vaccine. Effectiveness of immunization with small intradermal or subcutaneous doses. JAMA 1982; 247:1138-42; PMID:7057603; http://dx.doi.org/10.1001/jama.1982.03320330034022
   PubMed Web of Science ®Google Scholar
• McAllister L, Anderson J, Werth K, Cho I, Copeland K, Le Cam NB, Plant D, Mendelman PM, Cobb DK. Needle-free jet injection for administration of influenza vaccine: A randomised non-inferiority trial. Lancet 2014; 384:674-81; PMID:24881803; http://dx.doi.org/10.1016/S0140-6736(14)60524-9
   PubMed Web of Science ®Google Scholar
• Meyer Jr, Harry M, Daniel D. Hostetler Jr, Bernheim BC, Rogers NG, Lambin P, Chassary A, Labusquière R, Smadel JE. Response of Volta children to jet inoculation of combined live measles, smallpox and yellow fever vaccines. Bull World Health Organ 1964; 30:783-94; PMID:14215185. http://apps.who.int/iris/bitstream/10665/73714/1/bulletin_1964_30%286%29_783-794.pdf?ua=1
   PubMedGoogle Scholar
• Kendall MAF. Needle-free vaccine injection. Drug Delivery Handbook Exp Pharmacol 2010; 197:193-219; http://dx.doi.org/10.1007/978-3-642-00477-3_7
   PubMedGoogle Scholar
• Norman JJ, Arya JM, McClain MA, Frew PM, Meltzer MI, Prausnitz MR. Microneedle patches: Usability and acceptability for self-vaccination against influenza. Vaccine 2014; 32:1856-62; PMID:24530146; http://dx.doi.org/10.1016/j.vaccine.2014.01.076
   PubMed Web of Science ®Google Scholar
• Leroux-Roels I, Weber F. Intanza® 9 μg intradermal seasonal influenza vaccine for adults 18 to 59 years of age. Hum Vaccines Immunother 2013; 9:115-21; PMID:23442585; http://dx.doi.org/10.4161/hv.22342
   PubMed Web of Science ®Google Scholar
• Eizenberg P, Booy R, Naser N, Mason G, Stamboulian D, Weber F. Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina. Adv Ther 2011; 28:640-9; PMID:21751080; http://dx.doi.org/10.1007/s12325-011-0042-0
   PubMed Web of Science ®Google Scholar
• Prymula R, Usluer G, Altinel S, Sichova R, Weber F. Acceptance and opinions of Intanza/IDflu intradermal influenza vaccine in the Czech Republic and Turkey. Adv Ther 2012; 29:41-52; PMID:22228256; http://dx.doi.org/10.1007/s12325-011-0090-5
   PubMed Web of Science ®Google Scholar
• Gardeniers HJ, Luttge R, Berenschot EJ, De Boer MJ, Yeshurun SY, Hefetz M, van den Berg A. Silicon micromachined hollow microneedles for transdermal liquid transport. J Microelectromech Syst 2003; 12:855-62; http://dx.doi.org/10.1109/JMEMS.2003.820293
   Web of Science ®Google Scholar
• Rebeiz GM. RF MEMS: Theory, Design, and Technology. John Wiley & Sons 2004
   Google Scholar
• Nadim Maluf and Kirt Williams. An Introduction to Microelectromechanical Systems Engineering, Second Edition Hardcover - June 30, 2004.
   Google Scholar
• Della Cioppa G, Nicolay U, Lindert K, Leroux-Roels G, Clement F, Castellino F, Galli G1, Groth N, Levin Y, Del Giudice G. A dose-range study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration. Hum Vaccines Immunother 2014; 10:6, 1-10; PMID:24732325; http://dx.doi.org/10.4161/hv.28618
   PubMedGoogle Scholar
• Hung IF, Levin Y, To KK, Chan KH, Zhang AJ, Li P, Li C, Xu T, Wong TY, Yuen KY. Dose sparing intradermal trivalent influenza (2010/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain. Vaccine 2012; 30:6427-35; PMID:22910287; http://dx.doi.org/10.1016/j.vaccine.2012.08.014
   PubMed Web of Science ®Google Scholar
• Rappuoli R, Mandl CW, Black S, De Gregorio E. Vaccines for the twenty-first century society. Nat Rev Immunol 2011; 11:865-72; http://dx.doi.org/10.1038/nri3085
   PubMed Web of Science ®Google Scholar
• Chiu SS, Chan KH. Tu W, Lau YL, Peiris JS. Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: A randomized controlled trial. Vaccine 2009; 27:4834-9; PMID:19523908; http://dx.doi.org/10.1016/j.vaccine.2009.05.066
   PubMed Web of Science ®Google Scholar
• Ploin D, Schwarzenbach F, Dubray C, Nicolas JF, Goujon C, Trong MD, Laurent PE. Echographic measurement of skin thickness in sites suitable for intradermal vaccine injection in infants and children. Vaccine 2011; 29:8438-42; PMID:21821081; http://dx.doi.org/10.1016/j.vaccine.2011.07.111
   PubMed Web of Science ®Google Scholar
• Stephany Troy et al. Comparison of the Immunogenicity of Various Booster Doses of Inactivated Polio Vaccine Delivered Intradermally Versus Intramuscularly to HIV-Infected Adults. JID Advance Access published January 28, 2015; http://jid.oxfordjournals.org/content/early/2015/01/07/infdis.jiu841.full.pdf+html
   Google Scholar
• A new immunotherapy developed by the UK Company Circassia has the potential to make cat allergies an easily treatable condition. Human Vaccines Immunother 2013; 9:941-4; http://dx.doi.org/10.4161/hv.25213
   Google Scholar
• Riedmann E. A vaccine for long-suffering cat allergy patients. Human Vaccines & Immunotherapeutics: News. Hum Vaccines Immunother 2013, 9: 5, 941-944, DOI: 10.4161/hv.25213
   Google Scholar
• Investigational MAGE-A3 antigen-specific cancer immunotherapeutic does not meet first co-primary endpoints in MAGRIT, a phase III non-small cell lung cancer clinical trial. Issued: Thursday 20 March 2014, London UK; Retrieved June 23, 2014: http://www.gsk.com/media/press-releases/2014/investigational-MAGE-A3-antigen-specific-cancer-immunotherapeutic-does-not-meet-first-co-primary-endpoints-in-MAGRIT.html
   Google Scholar
• Tyagi P, Beloo M. MAGRIT: The largest-ever phase III lung cancer trial aims to establish a novel tumor-specific approach to therapy. Clin Lung Cancer 2009; 10:371-4; PMID:19808198; http://dx.doi.org/10.3816/CLC.2009.n.052
   PubMed Web of Science ®Google Scholar
• Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973; 137:1142-62; PMID:4573839; http://dx.doi.org/10.1084/jem.137.5.1142
   PubMed Web of Science ®Google Scholar
• Glenn GM, Kenney RT. Mass vaccination: Solutions in the skin. Curr Top Microbiol Immunol 2006; 304:247-68; PMID:16989274; http://dx.doi.org/10.1007/3-540-36583-4_14
   PubMed Web of Science ®Google Scholar
• Couzin-Frankel. Cancer immunotherapy. Science 2013; 342:1432-3; http://dx.doi.org/10.1126/science.342.6165.1432
   PubMed Web of Science ®Google Scholar